Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Richard Holt PhD, FRCP

Richard I. G. Holt PhD, FRCP

Professor in Diabetes and Endocrinology, Faculty of Medicine, University of Southampton; Honorary Consultant Physician, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

Richard Holt trained at the University of Cambridge and the London Hospital Medical College. He is Professor in Diabetes and Endocrinology at the University of Southampton and an Honorary Consultant Physician in Diabetes and Endocrinology at the University Hospital Southampton NHS Foundation Trust.

Professor Holt’s current research interests are broadly focussed around clinical diabetes but specifically encompass studies of the relationship between mental health and diabetes. His clinical responsibilities include the diabetes and pregnancy clinic, young adult diabetes clinic and the cystic fibrosis related diabetes service.

Professor Holt was the Editor-in-Chief of Diabetic Medicine (2016-2020) and is a past-Chair of the Council of Health Care Professionals of Diabetes UK. Professor Holt was a member of the 2008 NICE diabetes and pregnancy guideline development group and the NICE Type 2 diabetes: preventing the progression from pre-diabetes programme development group. Professor Holt is the Editor-in-Chief of the 5th edition of the Textbook of Diabetes. Professor Holt is the Chair of the EASD Committee for Clinical Affairs and was the EASD co-chair of the EASD-ADA consensus report of the management of type 1 diabetes in adults.


Prof. Holt has received honoraria for speaker engagements from EASD, Eli Lilly, Encore, Liberum, Novo Nordisk, and ROVI and funding for conference attendance from Novo Nordisk and Eli Lilly.